Azad Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 10:23 am

Competitors of Azad Engineering Ltd

All Competitor Stocks of Azad Engineering Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:50 pm

Below is a detailed analysis of the quarterly data for Azad Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 125.00 Cr. (Mar 2025) to 135.00 Cr., marking an increase of 10.00 Cr..
• For Expenses, as of Jun 2025, the value is 86.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79.00 Cr. (Mar 2025) to 86.00 Cr., marking an increase of 7.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2025) to 49.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 36.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 36.00%.
• For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 5.00 Cr..
• For Tax %, as of Jun 2025, the value is 29.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00%.
• For Net Profit, as of Jun 2025, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.64. The value appears strong and on an upward trend. It has increased from 4.03 (Mar 2025) to 4.64, marking an increase of 0.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:51 am

Growth

Last Updated: September 5, 2025, 2:31 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Azad Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 14.66. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 14.66, marking an increase of 3.46.
• For Diluted EPS (Rs.), as of Mar 25, the value is 14.66. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 14.66, marking an increase of 3.46.
• For Cash EPS (Rs.), as of Mar 25, the value is 17.97. This value is within the healthy range. It has increased from 13.38 (Mar 24) to 17.97, marking an increase of 4.59.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 215.82. It has increased from 109.12 (Mar 24) to 215.82, marking an increase of 106.70.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 215.82. It has increased from 109.12 (Mar 24) to 215.82, marking an increase of 106.70.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 70.82. It has increased from 57.65 (Mar 24) to 70.82, marking an increase of 13.17.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 26.62. This value is within the healthy range. It has increased from 25.13 (Mar 24) to 26.62, marking an increase of 1.49.
• For PBIT / Share (Rs.), as of Mar 25, the value is 22.05. This value is within the healthy range. It has increased from 21.66 (Mar 24) to 22.05, marking an increase of 0.39.
• For PBT / Share (Rs.), as of Mar 25, the value is 19.20. This value is within the healthy range. It has increased from 13.67 (Mar 24) to 19.20, marking an increase of 5.53.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 13.40. This value is within the healthy range. It has increased from 9.91 (Mar 24) to 13.40, marking an increase of 3.49.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 13.52. This value is within the healthy range. It has increased from 9.91 (Mar 24) to 13.52, marking an increase of 3.61.
• For PBDIT Margin (%), as of Mar 25, the value is 37.58. This value is within the healthy range. It has decreased from 43.60 (Mar 24) to 37.58, marking a decrease of 6.02.
• For PBIT Margin (%), as of Mar 25, the value is 31.13. This value exceeds the healthy maximum of 20. It has decreased from 37.57 (Mar 24) to 31.13, marking a decrease of 6.44.
• For PBT Margin (%), as of Mar 25, the value is 27.11. This value is within the healthy range. It has increased from 23.70 (Mar 24) to 27.11, marking an increase of 3.41.
• For Net Profit Margin (%), as of Mar 25, the value is 18.92. This value exceeds the healthy maximum of 10. It has increased from 17.19 (Mar 24) to 18.92, marking an increase of 1.73.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.09. This value is within the healthy range. It has increased from 17.19 (Mar 24) to 19.09, marking an increase of 1.90.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.26. This value is below the healthy minimum of 15. It has decreased from 9.08 (Mar 24) to 6.26, marking a decrease of 2.82.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.73. This value is below the healthy minimum of 10. It has decreased from 18.32 (Mar 24) to 8.73, marking a decrease of 9.59.
• For Return On Assets (%), as of Mar 25, the value is 4.69. This value is below the healthy minimum of 5. It has decreased from 7.34 (Mar 24) to 4.69, marking a decrease of 2.65.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 24) to 0.12, marking an increase of 0.08.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.17. This value is within the healthy range. It has increased from 0.05 (Mar 24) to 0.17, marking an increase of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. It has decreased from 0.49 (Mar 24) to 0.34, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 5.20. This value exceeds the healthy maximum of 3. It has increased from 4.29 (Mar 24) to 5.20, marking an increase of 0.91.
• For Quick Ratio (X), as of Mar 25, the value is 4.38. This value exceeds the healthy maximum of 2. It has increased from 2.94 (Mar 24) to 4.38, marking an increase of 1.44.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 4. It has increased from 0.60 (Mar 24) to 0.65, marking an increase of 0.05.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 14.09 (Mar 24) to 0.00, marking a decrease of 14.09.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.43 (Mar 24) to 0.00, marking a decrease of 10.43.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 85.91 (Mar 24) to 0.00, marking a decrease of 85.91.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.57 (Mar 24) to 0.00, marking a decrease of 89.57.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.35. This value is within the healthy range. It has increased from 3.14 (Mar 24) to 9.35, marking an increase of 6.21.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.71. This value is within the healthy range. It has increased from 2.24 (Mar 24) to 5.71, marking an increase of 3.47.
• For Enterprise Value (Cr.), as of Mar 25, the value is 8,332.22. It has increased from 8,045.07 (Mar 24) to 8,332.22, marking an increase of 287.15.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 18.22. This value exceeds the healthy maximum of 3. It has decreased from 23.61 (Mar 24) to 18.22, marking a decrease of 5.39.
• For EV / EBITDA (X), as of Mar 25, the value is 48.47. This value exceeds the healthy maximum of 15. It has decreased from 54.15 (Mar 24) to 48.47, marking a decrease of 5.68.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 19.21. This value exceeds the healthy maximum of 3. It has decreased from 23.67 (Mar 24) to 19.21, marking a decrease of 4.46.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 85.90 (Mar 24) to 0.00, marking a decrease of 85.90.
• For Price / BV (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has decreased from 12.51 (Mar 24) to 6.30, marking a decrease of 6.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 19.21. This value exceeds the healthy maximum of 3. It has decreased from 23.67 (Mar 24) to 19.21, marking a decrease of 4.46.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness